In this literature review, we examine how TR-FRET and Alpha technologies are being used to profile promising molecules targeting key GPCRs such as GLP-1R, GIPR, MC4R, and more. Drawing from recent studies on Tirzepatide, GL0034, and nanobody agonists, the review showcases:
For research use only. Not for use in diagnostic procedures.
Homogenous fluorescent assay applications for the characterization of anti-obesity molecules.